Compare Cronos Group Inc (CRON) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while YieldMax Universe Fund of Option Income ETFs trades at $7.56 (market cap $369.61M). The key difference: Cronos Group Inc is far larger — about 3.2× YieldMax Universe Fund of Option Income ETFs's market cap, and Cronos Group Inc is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and YieldMax Universe Fund of Option Income ETFs for 55 Days on average.
| CRON | YMAX | |
|---|---|---|
Market Cap | $1.20B | $369.61M |
Volume | 450,387 | 659,132 |
Sector | Health | Income / Options Overlay |
52-Week High | $3.55 | $12.98 |
52-Week Low | $2.30 | $7.27 |
Typical Hold Time | 22 Days | 55 Days |
Enterprise Value | $401.73M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
YMAX trades at $7.53, down 1.83% on the day, with a bearish technical signal driven by moving averages. The ETF maintains a high distribution yield with weekly dividends, though recent coverage highlights concerns about NAV erosion and sustainability. Technical indicators show mixed signals with RSI neutral but ADX suggesting selling pressure, while support levels cluster around $7-8.
The outlook remains cautious due to structural concerns about distribution sustainability and NAV performance. While the high yield attracts income investors, the fund faces risks from its fee structure and portfolio strategy. Analyst sentiment appears mixed with some highlighting yield benefits while others warn of principal erosion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
